• Fucoidan Workflows for Cancer Research

  2026-09-30

  Translate Fucoidan biology into reproducible cancer and immunology workflows, from apoptosis screening to VEGF and NK-cell assays. A practical bridge to EBV-associated cancer plasticity research clarifies what is established, what is exploratory, and how to troubleshoot formulation and mechanism.

• Sisomicin: Practical Antibacterial Research Workflows

  2026-09-29

  Sisomicin supports mechanistic ribosome studies, susceptibility testing, time-kill experiments, and targeted infection-model design across clinically relevant bacterial panels. This guide emphasizes assay selection, resistance-aware comparisons, formulation, and troubleshooting so researchers can turn aminoglycoside activity into reproducible data.

• Senescence Signatures in Abdominal Aortic Aneurysm

  2026-09-29

  The reference study integrates transcriptomic analysis, machine learning, independent validation, and single-cell data to identify cellular senescence-related signatures in abdominal aortic aneurysm. Its strongest candidates, ETS1 and ITPR3, connect diagnostic biomarker development with a senescent endothelial-cell mechanism while highlighting the need for prospective clinical validation.

• Angiotensin II: From GPCR Signal to Translational Model

  2026-09-28

  A mechanistic and strategic guide to using Angiotensin II across cardiomyocyte, vascular, and chronic remodeling models, with evidence-based interpretation of the miR-1268a–CD36 pathway and practical guidance for experimental design.

• Multiplex PBMC Flow Cytometry for Immunomodulator Screening

  2026-09-28

  Brox and Hackstein developed a multiparametric flow cytometry assay that reads out T-cell proliferation and activation alongside B-cell costimulation in human PBMCs. Its Z-factor-based validation and pilot screen show how integrated cellular phenotypes can improve immunomodulator screening, while also highlighting the need to interpret activity alongside donor variability, assay scope, and compound toxicity.

• Saikosaponins Suppress Hedgehog Signaling in Medulloblastoma

  2026-09-27

  Luo and colleagues report that saikosaponin B1 and saikosaponin D reduce Hedgehog-pathway output and inhibit medulloblastoma allograft growth, with experiments locating their functional action at or upstream of Smoothened. The study combines a reporter assay, pathway-bypass tests, and an in vivo tumor model, offering preclinical evidence for pathway-directed tumorigenesis studies rather than proof of clinical efficacy.

• HyperPFU™ High-Fidelity DNA Polymerase PCR Guide

  2026-09-26

  HyperPFU™ high-fidelity DNA polymerase is a proofreading DNA polymerase for difficult PCR targets, including long and GC-rich DNA fragments, when sequence accuracy and blunt-ended products are important. It is not a direct fit for workflows that require 3′-A overhangs or sticky ends unless the amplicon is subsequently processed for that purpose.

• Angiotensin II Workflows for Cardiac Remodeling

  2026-09-25

  Use Angiotensin II to connect receptor-driven signaling with practical cell and animal models of vascular and cardiac remodeling. This guide pairs product-based dosing benchmarks with a macrophage-focused heart-failure study, while separating reported findings from workflow recommendations.

• N-MYC–eIF4G1 Signaling Sustains inv(16) AML

  2026-09-25

  Peramangalam et al. identify N-MYC as a survival regulator in inv(16) acute myeloid leukemia and connect its activity to the previously unrecognized AML effector eIF4G1. Their findings link CBFβ-SMMHC inhibition with reduced MYCN expression and support further investigation of the N-MYC/eIF4G1 axis in leukemia models.

• Oxaliplatin: From DNA Damage to Translational Strategy

  2026-09-24

  Oxaliplatin is more than a cytotoxic benchmark: its DNA-damaging activity offers researchers a way to interrogate apoptosis, drug response and the limits of biomarker transfer. This article connects its mechanism and practical use with evidence from a bladder cancer CRISPR screen, highlighting why platinum agents should be evaluated individually in translational studies.

• Irinotecan Workflows for Cancer and Toxicity Models

  2026-09-24

  Use Irinotecan (CPT-11) to build interpretable topoisomerase I response experiments in colorectal cancer models, then extend the workflow to chemotherapy-associated gut–liver injury questions. Practical dosing, controls, and troubleshooting help distinguish compound handling problems from real biological variation.

• GSK 2837808A: A Selective LDHA Inhibitor

  2026-09-23

  GSK 2837808A is a potent lactate dehydrogenase A inhibitor reported to reduce glucose consumption and reverse aerobic glycolysis in cancer-cell experiments. Its established product evidence includes LDHA/LDHB potency and pharmacokinetic limitations; its use to test the NAT1–ENO1–lactate–PD-L1 pathway in colorectal cancer remains exploratory.

• Biomimetic Microparticles Disrupt Tumor pH Balance

  2026-09-23

  The reference study presents tumor cell-derived microparticles that co-deliver syrosingopine and a pH-activated doxorubicin prodrug to disrupt both intracellular and extracellular tumor pH homeostasis. By coupling lactate-export blockade with immunogenic chemotherapy and immune remodeling, the platform offers a mechanistically integrated approach to chemo-immunotherapy.

• HyperPFU™ high-fidelity DNA polymerase Guide

  2026-09-22

  HyperPFU™ high-fidelity DNA polymerase is intended for accurate amplification of long, GC-rich, inhibitor-containing, or otherwise difficult DNA templates. It is appropriate for blunt-ended products used in cloning and sequencing, but not for workflows that require 3′-A overhangs or predefined sticky ends.

• EZ Cap™ Cas9 mRNA for Functional Gene Studies

  2026-09-22

  Use transient Cas9 expression to test gene function without committing to a DNA-based expression system. This guide connects EZ Cap™ Cas9 mRNA (5-moUTP) with zebrafish neurodegeneration workflows, neural-cell assays, and practical troubleshooting for CRISPR-Cas9 genome editing.

8002 records 1/534 page Next 12345 下5页 Last page